Medscape

Cardiac Resynchronization Therapy for the Treatment of Heart Failure

6MWD: 6-min walk distance; CARE-HF: Cardiac Resynchronization-Heart Failure; COMPANION: Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure; CRT-D: Cardiac resynchronization ...
TCTMD

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-D) Devices

Medtronic CRT-D Devices Demonstrate Survival Benefits for Mildly Symptomatic Heart Failure Patients in Two Pivotal Clinical Trials MINNEAPOLIS – Medtronic, Inc. today announced that the U.S. Food and ...
Nature

Does cardiac resynchronization therapy reduce the long-term mortality risk in patients with heart failure?

Cardiac resynchronization therapy (CRT), with or without a defibrillator, has been shown to improve symptoms, quality of life, and prognosis in patients with moderate-to-severe heart failure (HF) ...
Science Daily

Most eligible patients miss out on cardiac resynchronization therapy for heart failure

Less than half of patients with heart failure likely to benefit from a pacemaker including the capacity for cardiac resynchronization therapy (CRT) actually receive such an implantable device. Most ...
TCTMD

Medtronic Announces FDA Approval of New Portfolio of Next-Gen Cardiac Resynchronization Therapy Devices, Implantable Cardioverter-Defibrillators

The next-gen Viva CRT-D and Evera defibrillation devices are shaped for patient comfort with a new, contoured design that reduces skin pressure by 30 percent, deliver greater battery longevity and ...
Nature

Can cardiac-resynchronization therapy reduce mortality in patients suffering from advanced chronic heart failure?

Intraventricular conduction delays are found in 15–30% of patients suffering from advanced chronic heart failure and lead to a reduction in systolic function and increased systolic volume. In ...
News Medical

UVA researcher receives Trailblazer R21 Award to improve cardiac resynchronization therapy outcomes

Pacemakers and other implantable devices that restore normal heart rhythms have saved millions of lives. In some patients, a pacemaker or implantable cardioverter defibrillator modified for "cardiac ...
Science Daily

Study Puts Brakes On Extending Indications For Cardiac Resynchronization Therapy

A randomized, controlled, multi-center trial has found that cardiac resynchronization therapy produced no improvement in peak oxygen uptake during exercise testing, the trial's primary endpoint, in ...
Nasdaq

Medtronic Receives CE Mark for Cobalt™ and Crome™ Portfolio of BlueSync™-Enabled Implantable Defibrillators, Cardiac Resynchronization Therapy-Defibrillators

DUBLIN, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced it has received CE (Conformité Européenne) Mark for its Cobalt™ and Crome™ portfolio of implantable ...
Business Insider

Cardiac Resynchronization Therapy Market Worth $5.1 Billion by 2024 - Exclusive Report by MarketsandMarkets™

CHICAGO, April 17, 2019 /PRNewswire/ -- According to the new market research report "Cardiac Resynchronization Therapy Market by Product Type (Cardiac Resynchronization Therapy Defibrillator and ...
FiercePharma

FDA Advisory Panel Recommends Expanded Indication for Medtronic Cardiac Resynchronization Therapy with Defibrillator (CRT-

MINNEAPOLIS--(BUSINESS WIRE)-- Medtronic, Inc. (NYSE: MDT) today announced that the U.S. Food and Drug Administration’s (FDA) Circulatory Systems Devices Advisory Panel determined that the overall ...